- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Challenges of New Approaches in Metastatic Merkel Cell Carcinoma ; volume:13 ; number:2 ; year:2020 ; pages:501-507
Case reports in oncology ; 13, Heft 2 (2020), 501-507
- Creator
-
Monteiro, Ana
Gouveia, Emanuel
Garcez, Daniela
Donato, Sara
Martins-Branco, Diogo
Marques, Joana
Nunes, Hugo
Passos, Maria José
Clara, Ana Isabel
Moreira, António
- DOI
-
10.1159/000507279
- URN
-
urn:nbn:de:101:1-2020100101470379056095
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.20252025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Monteiro, Ana
- Gouveia, Emanuel
- Garcez, Daniela
- Donato, Sara
- Martins-Branco, Diogo
- Marques, Joana
- Nunes, Hugo
- Passos, Maria José
- Clara, Ana Isabel
- Moreira, António
Other Objects (12)
Metastatic Merkel cell carcinoma response to nivolumab
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Scientific basics for new immunotherapeutic approaches towards Merkel cell carcinoma
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
Merkel Cell Carcinoma: Investigations on its carcinogenesis and new therapeutic approaches
Merkel cell carcinoma
Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
Two Clinical Cases of Metastatic Merkel Cell Carcinoma Illustrating Avelumab Tolerability in Elderly Patients
Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world
Metastatic Merkel cell carcinoma response to nivolumab
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Scientific basics for new immunotherapeutic approaches towards Merkel cell carcinoma
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
Merkel Cell Carcinoma: Investigations on its carcinogenesis and new therapeutic approaches
Merkel cell carcinoma
Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
Two Clinical Cases of Metastatic Merkel Cell Carcinoma Illustrating Avelumab Tolerability in Elderly Patients
Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world
Metastatic Merkel cell carcinoma response to nivolumab
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Scientific basics for new immunotherapeutic approaches towards Merkel cell carcinoma
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
Merkel Cell Carcinoma: Investigations on its carcinogenesis and new therapeutic approaches
Merkel cell carcinoma
Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
Two Clinical Cases of Metastatic Merkel Cell Carcinoma Illustrating Avelumab Tolerability in Elderly Patients